Study Offers Promise for Multicancer Detection from a Single Blood Draw
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read More
Search Results for: prostate cancer
Caris Life Sciences and Ambry Genetics Team Up to Advance Cancer Care
The partnership combines Caris’ somatic and Ambry’s germline testing to provide unique information about the molecular and genetic components of a patient’s cancer.
Read More
MolDx Issues LCD for Decipher Prostate Biopsy Genomic Test
The Medicare LCD provides coverage for the Decipher prostate biopsy genomic test for men with both favorable and unfavorable intermediate-risk prostate cancer.
Read More
Navify Guidelines App Offers Clinicians Guidance for Patients with Common Cancers
The Navify guidelines app pulls the latest clinical guidance for breast, colorectal, non-small cell lung, and prostate cancers from the National Comprehensive Cancer Network.
Read More
Trial Demonstrates Potential of Blood Test to Reduce Late Detection of Lung Cancer
The Early Detection for Cancer of the Lung Scotland trial is believed to be the world’s largest trial for the detection of lung cancer using biomarkers.
Read More